Suzanne Kamel‐Reid

19.3k total citations · 3 hit papers
285 papers, 12.1k citations indexed

About

Suzanne Kamel‐Reid is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Suzanne Kamel‐Reid has authored 285 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Hematology, 88 papers in Oncology and 81 papers in Molecular Biology. Recurrent topics in Suzanne Kamel‐Reid's work include Chronic Myeloid Leukemia Treatments (65 papers), Cancer Genomics and Diagnostics (60 papers) and Lung Cancer Treatments and Mutations (52 papers). Suzanne Kamel‐Reid is often cited by papers focused on Chronic Myeloid Leukemia Treatments (65 papers), Cancer Genomics and Diagnostics (60 papers) and Lung Cancer Treatments and Mutations (52 papers). Suzanne Kamel‐Reid collaborates with scholars based in Canada, United States and United Kingdom. Suzanne Kamel‐Reid's co-authors include Ming‐Sound Tsao, John E. Dick, Gilda da Cunha Santos, Frances A. Shepherd, Jeremy A. Squire, Tong Zhang, Patrick Gullane, Lesley Seymour, Ni Liu and Akira Sakurada and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Suzanne Kamel‐Reid

281 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

2005 1.5k citations Ming‐Sound Tsao, Akira Sakurada et al. profile →
Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

2008 561 citations Chang‐Qi Zhu, Gilda da Cunha Santos et al. Journal of Clinical Oncology profile →
Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

2017 451 citations Suzanne Kamel‐Reid et al. Journal of Molecular Diagnostics profile →

Peers

Countries citing papers authored by Suzanne Kamel‐Reid

Since Specialization

Citations

This map shows the geographic impact of Suzanne Kamel‐Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Kamel‐Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Kamel‐Reid more than expected).

Fields of papers citing papers by Suzanne Kamel‐Reid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Kamel‐Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Kamel‐Reid. The network helps show where Suzanne Kamel‐Reid may publish in the future.

Co-authorship network of co-authors of Suzanne Kamel‐Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Kamel‐Reid. A scholar is included among the top collaborators of Suzanne Kamel‐Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Kamel‐Reid. Suzanne Kamel‐Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors 2019 ·International Journal of Gynecological Pathology ·Ghassan Allo, Mei Ling Yap, Julie Cuartero, Michael Milosevic, Sarah E. Ferguson, Helen Mackay, Suzanne Kamel‐Reid, Ilan Weinreb, Danny Ghazarian, Melania Pintilie, Blaise Clarke	45
2	P2.03-03 Upfront Next Generation Sequencing in NSCLC: A Publicly Funded Perspective 2018 ·Journal of Thoracic Oncology ·(unknown), Tracy Stockley, Ming‐Sound Tsao, Joshua C. Morganstein, Suzanne Kamel‐Reid, (unknown), F. Shepherd, Penelope A. Bradbury, (unknown), D. Hwang, Prodipto Pal, Joerg Schwock, Scott Boerner, Adrian G. Sacher, (unknown), N. B. Leighl	0
3	Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation 2018 ·The Journal of Pathology Clinical Research ·Aoife J McCarthy, José‐Mario Capo‐Chichi, Tara Spence, (unknown), Tracy Stockley, Suzanne Kamel‐Reid, Stefano Serra, Peter Sabatini, Runjan Chetty	100
4	Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma 2017 ·International Journal of Cancer ·Jeremy Lewin, Swati Garg, (unknown), Brendan C. Dickson, Frank Traub, Nalan Gökgöz, Anthony M. Griffin, Peter C. Ferguson, Irene L. Andrulis, Hao‐Wen Sim, Suzanne Kamel‐Reid, Tracy Stockley, Lillian L. Siu, Jay S. Wunder, Albiruni R. Abdul Razak	23
5	Interim Results of the Canadian Tyrosine Kinase Inhibitor Discontinuation Trial for 2nd Attempt of Treatment Free Remission: Treatment Free Remission Accomplished By Dasatinib (TRAD) 2017 ·Blood ·Dennis Kim, Isabelle Bence‐Bruckler, Donna L. Forrest, Lynn Savoie, Stephen Couban, Lambert Busque, Robert Delage, Pierre Laneuville, (unknown), Anargyros Xenocostas, Kristjan Paulson, Suzanne Kamel‐Reid, Jeffrey H. Lipton, Brian Leber	7
6	Treatment options for patients with brain metastases from EGFR / ALK -driven lung cancer 2017 ·Radiotherapy and Oncology ·Mark Doherty, Grzegorz Korpanty, Pascale Tomasini, (unknown), Kevin Jao, Catherine Labbé, Céline Mascaux, Petra Martin, Suzanne Kamel‐Reid, Ming‐Sound Tsao, Melania Pintilie, Geoffrey Liu, Penelope A. Bradbury, Ronald Feld, Natasha B. Leighl, Caroline Chung, Frances A. Shepherd	40
7	A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma 2016 ·Journal of Clinical Pathology ·Gilda da Cunha Santos, (unknown), (unknown), Mauro Saieg, Bethany Pitcher, Melania Pintilie, Suzanne Kamel‐Reid, Ming‐Sound Tsao	15
8	Malignant Melanoma of Vulva and Vagina 2015 ·Journal of Lower Genital Tract Disease ·Marjan Rouzbahman, Suzanne Kamel‐Reid, Ayman Al Habeeb, Marcus O. Butler, Jason Dodge, Stéphane Laframboise, Joan Murphy, Golnar Rasty, Danny Ghazarian	36
9	Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study 2012 ·Journal of Clinical Oncology ·Teresa M. Petrella, Richard Tozer, Karl Bélanger, Kerry J. Savage, Ralph Wong, Michael Smylie, Suzanne Kamel‐Reid, Victor A. Tron, Bingshu E. Chen, Naomi Hunder, Linda Hagerman, Wendy Walsh, Elizabeth A. Eisenhauer	95
10	The use of FTA cards for preserving unfixed cytological material for high‐throughput molecular analysis 2012 ·Cancer Cytopathology ·Mauro Saieg, William R. Geddie, Scott Boerner, Ni Liu, Ming‐Sound Tsao, Tong Zhang, Suzanne Kamel‐Reid, Gilda da Cunha Santos	31
11	Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer 2010 ·Cancer ·Gilda da Cunha Santos, Neesha C. Dhani, Dongsheng Tu, (unknown), Olga Ludkovski, Suzanne Kamel‐Reid, Jeremy A. Squire, Wendy R. Parulekar, Malcolm J. Moore, Ming‐Sound Tsao	117
12	Detection of EGFR and KRAS mutations in fine‐needle aspirates stored on Whatman FTA cards 2010 ·Cancer Cytopathology ·Gilda da Cunha Santos, Ni Liu, Ming‐Sound Tsao, Suzanne Kamel‐Reid, (unknown), William R. Geddie	37
13	Comprehensive evaluation of time‐to‐response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: Which parameter at which time‐point does matter? 2010 ·American Journal of Hematology ·Dong Hwan Kim, (unknown), Chul Won Jung, Suzanne Kamel‐Reid, Jerald P. Radich, Jeffrey H. Lipton	9
14	Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation 2010 ·Leukemia Research ·Allan Jiang, Hua Jiang, Joseph Brandwein, Suzanne Kamel‐Reid, Hong Chang	17
15	Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia 2009 ·Clinical Cancer Research ·Dong Hwan Kim, (unknown), Wei Xu, Suzanne Kamel‐Reid, Xiangdong Liu, Katherine Siminovitch, Hans A. Messner, Jeffrey H. Lipton	154
16	Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 breakdown → 2008 ·Journal of Clinical Oncology ·Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding, Akira Sakurada, Jean-Claude Cutz, Ni Liu, Tong Zhang, Paula Marrano, Marlo Whitehead, Jeremy A. Squire, Suzanne Kamel‐Reid, Lesley Seymour, Frances A. Shepherd, Ming‐Sound Tsao	561
17	No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia 2008 ·Cancer ·Dong Hwan Kim, Gizelle Popradi, (unknown), Suzanne Kamel‐Reid, Hong Chang, Hans A. Messner, Jeffrey H. Lipton	22
18	Inter-Laboratory Comparison of Chronic Myeloid Leukemia Minimal Residual Disease Monitoring 2007 ·Journal of Molecular Diagnostics ·Tong Zhang, (unknown), (unknown), Cuihong Wei, Jeffrey H. Lipton, Suzanne Kamel‐Reid	36
19	Correlation of Epstein‐Barr virus DNA in cell‐free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: A pilot study 2004 ·Head & Neck ·Antti Mäkitie, Patrícia P. Reis, Jonathan Irish, Tong Zhang, Soo Chin, Xueyu Chen, (unknown), Anne Keller, Bayardo Perez‐Ordoñez, Suzanne Kamel‐Reid, Lillian L. Siu	22
20	Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis 2004 ·International Journal of Cancer ·(unknown), Patrícia P. Reis, Igor Jurišica, (unknown), Shilpi Arora, Christina MacMillan, Antti Mäkitie, Reidar Grénman, Nancy Reid, Mahadeo A. Sukhai, Jeremy L. Freeman, Patrick Gullane, Jonathan Irish, Suzanne Kamel‐Reid	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact